Boehringer Ingelheim Vetmedica, Inc., has commended the Racing Medication and Testing Consortium (RMTC) for its recent decision to wait on the results of a UC Davis study before ruling on a possible ban of clenbuterol at horse racing tracks.
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.














